Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
9.13Price to Sales
VS
Market
Sector
Industry
History
$ 18Close
$ 3.93 - $ 21.42 52-Week Range
Ticker Information
Ticker
URGNCompany Name
UROGEN PHARMA LTDSector
HealthcareIndustry
BiotechnologyExchange
NASDAQUROGEN PHARMA LTD - Price to Sales Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
URGN - P/S Historical data
| Date | Market Capitalization | Price to Sales | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 860.05M | 9.13 | $ 94.24M |
| 3/31/2025 | $ 513.64M | 5.59 | $ 91.87M |
| 12/31/2024 | $ 457.26M | 5.06 | $ 90.4M |
| 9/30/2024 | $ 516.52M | 5.78 | $ 89.36M |
| 6/30/2024 | $ 630.03M | 7.41 | $ 85.01M |
| 3/31/2024 | $ 472.22M | 5.6 | $ 84.3M |
| 12/31/2023 | $ 488.97M | 5.91 | $ 82.71M |
| 9/30/2023 | $ 360.52M | 4.67 | $ 77.28M |
| 6/30/2023 | $ 642.3M | 8.86 | $ 72.52M |
| 3/31/2023 | $ 291.29M | 4.28 | $ 67.98M |
Key Performance Insights, Last 5 Years
- UROGEN PHARMA LTD's latest trailing twelve months (TTM) P/S stands at 143.46.
- Over the past 5 years, UROGEN PHARMA LTD's average P/S has been 14.67.
- The median P/S for UROGEN PHARMA LTD during this period was 5.69
- UROGEN PHARMA LTD reached its highest P/S over the past 5 years at 143.46.
- The lowest P/S recorded by UROGEN PHARMA LTD in the same timeframe 2.75
UROGEN PHARMA LTD's P/S vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
P/S Benchmarks
Similar metrics to Revenues:
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Price to Book - [Calculation] Measures a company’s [MarketCap] in relation to its [Equity] which is the value of [Assets] minus [Liabilities].
- Enterprise Value over Free Cash Flow - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its Free Cash Flow [FCF].
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
Definition of Price to Sales
[Calculation] Measures a company’s [MarketCap] in relation to its [Revenue].Market Cap / Revenues
(=) P/S P/S for UROGEN PHARMA LTD is calculated as follows: Market Cap [ $ 549.9M ] / Revenues [ $ 3.83M ]
(=) P/S [ 143.46 ] URGN - Price to Sales, Last 5 years
2.75
Minimum
Mar 31, 2022
143.46
Maximum
Sep 30, 2020
14.67
Average
5.69
Median
P/S Benchmark AnalysisMarket
The chart above depicts the distribution of P/S for companies in the Total Stock Market. The average P/S of the companies is 2.62 with a standard deviation of 2.38.
The following table provides additional summary stats:
P/S in the Market:
| filtered constituents | 3.42K |
|---|---|
| min | 0 |
| max | 11.15 |
| average | 2.62 |
| median | 1.97 |
| std | 2.38 |